Antifungal skin reactions David W Denning University Hospital
- Slides: 59
Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester
Itraconazole and exanthematous pustulosis Bx showed neutrophils in epidermis and neutrophils and eosinophils in the dermis Heymann J Am Acad Dermatol 1995; 33: 130; Min Park, JAAD 1997; 36: 754
Itraconazole erythematous eruption (AIDS) www. aspergillus. org. uk
Itraconazole and reported cutaneous reactions in the literature Adverse events Total number patients Number of patients 9065 Cutaneous side effects Rash/pruritus 250 Alopecia 19 Site reaction / vasculitis 4 Steven-Johnson syndrome 2 Hirsuitism 1 Photosensitivity 1 Diaphoresis 1 Unpublished
Patient 1 • AW (♂, age 56) was commenced on posaconazole 400 mg twice daily following progression of CPA despite itraconazole and voriconazole CPA had developed on a background of sarcoidosis. The only concurrent treatment was prednisolone 5 mg. Unpublished
Patient 1 Aug 2009 July 2010 Unpublished
Patient 1 • AW (♂, age 56) was commenced on posaconazole 400 mg twice daily following progression of CPA despite itraconazole and voriconazole CPA had developed on a background of sarcoidosis. The only concurrent treatment was prednisolone 5 mg. Random therapeutic drug monitoring (TDM) revealed levels of 2. 3 mg/l (normal range > 0. 5 mg/l). Within one month of commencing posaconazole he developed a sparse papular rash on his face and forearms. The rash did not progress and the patient continues on posaconazole. Unpublished
Patient 2 • DC (♂, age 73) was commenced on posaconazole 400 mg twice daily following progression of CPA despite itraconazole and voriconazole. CPA had developed on a background of asthma and ABPA. He also had severe aortic stenosis. Treatments included inhaled salmeterol/fluticasone 50/500 mcg twice daily and prednisolone 5 mg. Unpublished
Patient 2 Oct 2008 Jan 2010 Unpublished
Patient 2 • DC (♂, age 73) was commenced on posaconazole 400 mg twice daily following progression of CPA despite itraconazole and voriconazole. CPA had developed on a background of asthma and ABPA. He also had severe aortic stenosis. Treatments included inhaled salmeterol/fluticasone 50/500 mcg twice daily and prednisolone 5 mg. Random TDM revealed levels of 2. 8 mg/l. Within forty-eight hours of commencing posaconazole he developed a severe acneifrom rash, typical of folliculitis, across his face. Unpublished
Patient 2 Unpublished
Patient 2 • Within one week the rash had progressed to cover his neck, ears, scalp and upper chest wall. Posaconazole was discontinued due to the severe nature of the eruption. Unpublished
Patient 3 • JB (♂, age 61) was commenced on posaconazole 400 mg twice daily following progression of CPA despite itraconazole and intolerance of voriconazole due to photosensitivity. He had developed CPA following resection of lung cancer. Treatment included salmeterol/fluticasone 25/250 mcg 2 puffs twice daily and tiotropium 18 mcg daily. Random TDM revealed levels of 2. 6, mg/l. Within two weeks of commencing posaconazole he developed a sparse acneifrom rash on his face. A similar eruption had occurred on itraconazole. The rash did not progress and the patient continues on posaconazole. Unpublished
Patient 3 • JB (♂, age 61) was commenced on posaconazole 400 mg twice daily following progression of CPA despite itraconazole and intolerance of voriconazole due to photosensitivity. He had developed CPA following resection of lung cancer. Treatment included salmeterol/fluticasone 25/250 mcg 2 puffs twice daily and tiotropium 18 mcg daily. Unpublished
Patient 3 Sept 2008 Nov 2008 Unpublished
Patient 3 Unpublished
Patient 3 • JB (♂, age 61) was commenced on posaconazole 400 mg twice daily following progression of CPA despite itraconazole and intolerance of voriconazole due to photosensitivity. He had developed CPA following resection of lung cancer. Treatment included salmeterol/fluticasone 25/250 mcg 2 puffs twice daily and tiotropium 18 mcg daily. Random TDM revealed levels of 2. 6, mg/l. Within two weeks of commencing posaconazole he developed a sparse acneifrom rash on his face. A similar eruption had occurred on itraconazole. The rash did not progress and the patient continues on posaconazole. Unpublished
Patient 4 • NC (♂, age 73) was commenced on posaconazole 400 mg twice daily following progression of CPA despite itraconazole. He had developed CPA following resection of lung cancer. He had psoriasis for years, with little trouble and almost no treatment. Treatment included salmeterol/fluticasone 25/250 mcg 2 puffs twice daily and tiotropium 18 mcg daily. Unpublished
Patient 4 Jan 2010 Unpublished
Patient 4 • NC (♂, age 73) was commenced on posaconazole 400 mg twice daily following progression of CPA despite itraconazole. He had developed CPA following resection of lung cancer. He had psoriasis for years, with little trouble and almost no treatment. Treatment included salmeterol/fluticasone 25/250 mcg 2 puffs twice daily and tiotropium 18 mcg daily. Random TDM revealed levels of 2. 6, mg/l. After 3 weeks of posaconazole he had a remarkable exacerbation of psoriasis. He developed psoriatic plaques on his hands for the first time ever. The plaques on his lower legs became confluent. This occurred in association with worsening chest symptoms, notably increased coughing, more breathlessness and increasing oxygen requirement. Unpublished
Patient 4 Unpublished
Patient 4 Unpublished
Patient 4 • Posaconazole was stopped after 3 weeks, and 2 weeks later he was still very symptomatic with his chest. This responded to a 2 week course of corticosteroids, and his psoriasis also improved. Unpublished
Posaconazole and rash • A search of Medline and Embase databases revealed no previous reports of adverse cutaneous reactions due to posaconazole. The UK and US data sheets describe ‘rash’ (unspecified) as common, mouth ulceration and alopecia as uncommon and Stevens Johnson Syndrome and ‘vesicular rash’ as rare. Unpublished
Voriconazole
Cheilitis, conjunctivitis and facial erythema with voriconazole
Voriconazole and photosensitivity (phototoxic reaction) 52 Denning & Griffiths J Exp Dermatol 2001; 26: 648
Voriconazole, photosensitivity and sunshine Denning & Griffiths J Exp Dermatol 2001; 26: 648
Photosensitivity and cutaneous blistering with voriconazole Voriconazole has ‘uncovered’ pophyria cutanea tarda, and may be mistaken for it (pseudoporphyria) WWW. aspergillus. org. uk
Voriconazole and pseudoporphyria Medscape
Patient 5 • AB (♀, age 40) treated with voriconazole (Study 003) having failed itraconazole. She was the first patient in the world with aspergillosis to be treated with voriconazole. Chronic invasive Aspergillus sinusitis and osteomyelitis of the base of the skull, with cranial neuropathies. Denning & Griffiths J Exp Dermatol 2001; 26: 648
Patient 5 Swift & Denning J Otol Laryngol 1998; 112: 92
Patient 5 Right hypglossal nerve palsy Right lateral rectus palsy Swift & Denning J Otol Laryngol 1998; 112: 92
Patient 5 Swift & Denning J Otol Laryngol 1998; 112: 92
Patient 5 • AB (♀, age 40) treated with voriconazole having failed itraconazole Chronic invasive Aspergillus sinusitis and osteomyelitis of the base of the skull. Past history of acne rosacea (5 years of antibiotics), not present on starting voriconazole. She received voriconazole for 411 days, 200 mg twice daily, starting on 12 July, 1993. After 4 weeks of therapy she developed cheilitis. Denning & Griffiths J Exp Dermatol 2001; 26: 648
Patient 5 She then went on holiday in the UK (Lincolnshire) for 2 weeks. At 8 weeks of therapy she reported erythema of her face, upperchest and ears. Her legs and arms tanned normally. Facial erythema and cheilitis apparent at each outpatient visit although less marked in February 1994. Summer of 1994, the facial erythema was worse following a holiday at the Mediterranean during which she had used SPF-15 sunscreen. Denning & Griffiths J Exp Dermatol 2001; 26: 648
Patient 5 Patient AB. First patient (in the world) with aspergillosis treated with voriconazole. Enrolled 2 July 1993 Swift J Otol Laryngol 1998; 112: 92. Denning & Griffiths J Exp Dermatol 2001; 26: 648
Patient 5 July 1994 she developed slightly pruritic, non-tender, 1 -2 cm diameter red plaques on both sides of her neck. Denning & Griffiths J Exp Dermatol 2001; 26: 648
Patient 5 Denning & Griffiths J Exp Dermatol 2001; 26: 648
Patient 5 July 1994 she developed slightly pruritic, non-tender, 1 -2 cm diameter red plaques on both sides of her neck. These plaques were clinically and histologically consistent with a diagnosis of discoid lupus erythematosus. Sunscreen of SPF-30 was recommended and some improvement was noted a month later. Her neck lesions and general erythema improved further over the following six weeks. Treatment with voriconazole was then stopped (completion of therapy). All her cutaneous abnormalities resolved over the following four months and she is free of aspergillosis three years later. Denning & Griffiths J Exp Dermatol 2001; 26: 648
Pustular phototoxic reaction with voriconazole
Voriconazole adverse events in asthmatics Chisimba, J Asthma In press
Voriconazole photosensitivity – cause? Inhibition of all-trans retinol (vitamin A)? 5/6 CF children developed photosensitivity, all on vitamin A supplementation The imidazole liarazole blocks retinoic acid 4 hydroxylase, raising all-trans retinoic acid
Patient 6 LT (♀, age 49) lifelong asthma and atopy, with ABPA diagnosed in 1993. Recognised to have CPA complicating ABPA in 2001, but the CPA diagnosis was apparent but made in 1993. Recurrent infective exacerbations and colonisation by Aspergillus fumigatus and Pseudomonas aeruginosa. Treated with oral itraconazole. www. aspergillus. org. uk
Patient 6 www. aspergillus. org. uk
Patient 6 Better pulmonary status on voriconazole initially, but then slow deterioration, On 4 l/min oxygen dependent 24 hours a day. Mild photosensitivity on voriconazole, even with little sun exposure. As wheelchair bound very little outside time, so mostly indoor light. She developed rough scaly patches over her face, neck and lower arms. Dermatological review indicated “multiple solar keratoses”. www. aspergillus. org. uk
Patient 6 Skin biopsy from the right forearm confirmed this clinical diagnosis – “skin showing hyperkeratosis with a little parakeratosis and acanthosis. The keratinocytes have a glassy appearance but show nuclear atypia with dyskeratotic cells, and occasional suprabasal mitoses. The intraepidermal sweat ducts are spared. Appearances suggest an actinic keratosis with moderate to severe dysplasia. ” These features are characteristic of a low grade premalignant change. She was treated with local 5 -fluorouracil cream (Efudix) (3 cycles) to the affected lesions. www. aspergillus. org. uk
Patient 6 www. aspergillus. org. uk
Patient 6 www. aspergillus. org. uk
Patient 6 These photos were taken at the apogee of inflammation. The inflammation resolved after discontinuing the cream. This reaction is expected with application of this mild chemotherapy agent. Following treatment her skin was much softer and considerably improved. Voriconazole has been stopped, and posaconazole substituted.
Patient 6 18 months later, new lesion on her forearm.
Patient 6 Biopsy showed squamous cell carcinoma in situ
Voriconazole and skin cancer
CGD and hyper Ig. E syndrome, aggressive multifocal SCCs, voriconazole for 4. 5 yrs Mc. Carthy Clin Infect Dis 2007; 44: e 55
CGD, multiple melanomas in situ, voriconazole for 4. 5 yrs Multiple melanomas in situ, voriconazole for 3 yrs Miller Arch Dermatol 2010; 146: 300
ALL, multiple SCCs in situ, voriconazole for 3 yrs HIV, SCC, on voriconazole for 15 months Cowen, J Am Acad Dermatol 2010; 62: 31
Prior methotrexate, multiple SCCs on scalp, voriconazole for 2 yrs CF & Lung Tx, aggressive SCCs, on voriconazole for 3. 5 yrs Epaulard, Clin Microbiol Infect 2010; 16: 1362
Multifocal Aggressive Squamous Cell Carcinomas Induced by Prolonged Voriconazole Therapy Pulmonary aspergillosis, skin carcinogenesis showed two variants of the MICR gene. Morice, Case Rep Med 2010
Summary and questions • Cutaneous adverse effects uncommon with itraconazole and posaconazole • Acneiform eruption a new adverse event with posaconazole • Photosensitivity, cheilitis and conjunctivitis common with voriconazole • Photosensitivity may develop into carcinoma in situ, Bowen’s dieases, squamous cell carcinoma or melanoma. • Photoaging not properly described separately • Mechanism of photosensitivity could involve elevated retinol levels locally, but not understood • Is there a limit to the duration of treatment of caucasians with voriconazole? • How should these patients be best monitored?
- Mucormycosis ppt
- Classification of antifungal drugs
- Types of antifungal drugs
- Nystatin nursing implications
- Antifungal drugs classification
- Antifungal sensitivity test
- Thrush creams boots
- Section 2 classifying chemical reactions worksheet answers
- Example of oxidation reduction reaction
- Chemical reactions section 2 classifying chemical reactions
- Chemical reactions section 3 reactions in aqueous solutions
- Unit 5 chemical reactions answers
- Objectives of interpretation
- Phil denning
- Graham-denning model
- Pamela arenas
- Nikki denning
- Lattice based access control example
- Stuffinspace
- Graham denning model
- Thick skin and thin skin
- Thin skin vs thick skin
- Basic facial steps milady
- Functions of hospital pharmacist
- University hospital of pisa
- Brendan rauw
- Benha university hospital
- Kyorin university ranking
- University hospital tuebingen
- Pisa pain
- Patras university hospital
- Pisa university hospital
- Original source
- Qah
- Kyung hee university hospital at gangdong
- Kaohsiung medical university hospital
- University of iowa hospital and clinics departments
- King saud university hospital nurse salary
- David phipps york university
- Hospital digomi
- David wishart university of alberta
- 詹景裕
- Enzyme cut-outs activity
- Proportional relationships in chemical reactions
- Balancing chemical equations definition
- Redox rules
- Types of reaction
- Five types of reactions
- Example of single replacement reaction
- Types of reactions chemistry
- Types of chemical reactions
- Predicting products of chemical reactions
- 4 types of chemical reactions
- Inputs of light reactions in photosynthesis
- Non examples of chemical reactions
- Chapter 10 chemical reactions answer key
- Antiperiplaner
- Elimination reaction of alkyl halides
- Tension compression
- The calculation of quantities in chemical equations